Skip to main content
. 2016 May 13;30(9):1832–1843. doi: 10.1038/leu.2016.83

Table 1. Mutations in the IL7R and its downstream activated molecules in 71 out of 146 pediatric T-ALL patients.

Pt # Oncogene Subtype IL7R JAK1 JAK3 STAT5B N-RAS K-RAS NF1 PTEN AKT NOTCH/ FBXW7
      Non-cysteine mutations                  
1 MLL nd V253WN  
2   ETP-ALL V253GPSL   PEST
      Cysteine mutations                  
3 TLX3 nd IL241-242CLEG   HD/PEST
4 TLX3 TLX PILLT240-244RFCPH A146T   HD
5 TLX3 TLX PILLTIS240-246LKC A146T  
6 TLX3 TLX LLT242-244FHPFNCGP G12D   HD
7 HOXA TLX L243RLECV   PEST
8 HOXA nd LL242-L243FPHQHC   FBXW7
9 SET-NUP214 TLX LLTIS242-246PQGGC   HD/FBXW7
10   nd PIL240-242QSPSC   HD
11   TLX LT243-244LMCPT   JM
12   TALLMO PILLTIS240-S246LQSC  
13 TLX3 TLX E668Q nd nd Del/333dupA HD/FBXW7
14 LYL1/LMO2 TALLMO L624YPILKV   JM/PEST
15   Proliferative V427M   HD/PEST
16 CALM-AF10 nd P815S   HD/PEST
17 RUNX1-AFF3 ETP-ALL T901G M511I   PEST
18   ETP-ALL R724H M511I G12D   PEST
19   ETP-ALL M511I nd nd Del/- PEST
20 TLX3 TLX M511I   JM
21 CALM-AF10 TLX R657Q   HD/PEST
22 TLX3 TLX R657Q nd nd   ND
23 TLX1 TLX N642H  
24 TLX1 TLX N642H   nd nd
25 LMO2 nd N642H   PEST
26 SIL-TAL1 TALLMO N642H   HD
27 TLX3 TLX G12D  
28 TLX3 TLX G12V   HD
29 TLX3 nd G12C   HD/FBXW7
30 TLX3 nd G13V   HD/FBXW7
31 CALM-AF10 ETP-ALL N642H G12D  
32 SIL-TAL1 nd G13C   Mut/Del
33 NKX2-5 ETP-ALL G13D   Mut/Mut/Subcl. Del HD
34   TALLMO G12R   FBXW7
35 TAL2 TALLMO G12D   no protein FBXW7
36 LMO2 TALLMO G12D  
37 TLX3 TLX Q61R   HD/FBXW7
38 MEF2C ETP-ALL Q61L   HD/PEST
39 CALM-AF10 ETP-ALL nd nd Del/3734delCinsGGTTTATGGTTT
40   nd G12D   HD
41 TLX3 TLX A146T   PEST
42 TLX3 TLX A146T   HD
43 LMO2 TALLMO A146T   HD/FBXW7
44 SIL-TAL1 TALLMO   Subcl. Del/— HD/PEST
45 SIL-TAL1 TALLMO   Mut/Mut
46 SIL-TAL1 TALLMO   Del/— HD
47 SIL-TAL1 TALLMO   Subcl. Del/—
48 SIL-TAL1 TALLMO   Subcl. Mut/—
49 SIL-TAL1 TALLMO A146T   Del/Del
50 SIL-TAL1 TALLMO   Del/Subcl. Del
51 SIL-TAL1 TALLMO   Del/Subcl. Del
52 SIL-TAL1 TALLMO   Mut/Mut
53 LMO3 TALLMO   Mut/Mut
54 LMO2 TALLMO   Mut/Mut FBXW7
55   TALLMO   Mut/Mut HD
56   TALLMO   Mut/Mut
57   TALLMO   Subcl. Del/—
58   TALLMO   Mut/Subcl. Del
59   TALLMO   Mut/Subcl. Del
60 NKX2—1 Proliferative   Mut/— HD/FBXW7
61 TAL1 Proliferative   no protein HD
62 SIL-TAL1 Proliferative   Mut/Mut
63 SIL-TAL1 Proliferative nd   Mut/Mut PEST
64   ETP-ALL nd   Del/— PEST
65 MYC nd   Mut/Del
66 LMO2 nd   Mut/Mut/Subcl. Del PEST
67   nd   Del/—
68   nd   Mut/Del
69 TLX1 Proliferative   E17K
70 TLX3 Proliferative   E17K FBXW7
71 LMO1 TALLMO   E17K

Abbreviations: nd, not done; T-ALL, T-cell acute lymphoblastic leukemia; —, tested negative. From a cohort of 146 screened pediatric T-ALL patients, 71 are listed with mutations in at least one of the following genes: IL7Ra, JAK1, JAK3, STAT5B, N-RAS, K-RAS, NF1, PTEN and AKT. The NOTCH/FBXW7 mutational status is listed in the last column.